Singapore is a recognized destination for clinical trials with multi-ethnic populations including 74% Chinese, 13% Malay and 9% Indian. Similarly, to what George Clinical provides in Hong Kong and Taiwan, Singapore offers regulatory services which includes acting as local sponsor while managing IP importations, project management, safety and pharmacovigilance (PV) reporting services. Key advantages of […]
Read More
George Clinical’s Philippines office is based in the capital city, Manila and compliments the organization’s list of global locations. Currently, the Philippines has a population of more than 100 million making it a rich source of patients with a high probability of recruiting treatment-native population. Key advantages of conducting clinical trials with George Clinical in […]
Read More
Australia has a longstanding history of conducting clinical trials to a high standard. Australia has a rich research environment, highly experienced investigators and research professionals, coupled with excellent health care infrastructure and a strong intellectual property regime. Many Australian investigators and researchers are world leaders in their field. There are many attractive features of research […]
Read More
New Zealand requires only one ethics committee review per study – reducing clinical trial start-up timelines. New Zealand has a respected reputation in medical research and is a place of innovation, honesty and entrepreneurial advancement. New Zealand offers a world class track record in early phase trials, proof of concept trials and independent, clean and […]
Read More
